top of page

Launch of Revvity – a PROXIDRUGS partner

Revvity, Inc., a science-based solutions company that leverages innovation across life sciences and diagnostics to help improve lives everywhere, officially launched May 9, 2023. Revvity, previously affiliated with PerkinElmer, Inc., and building on a legacy of innovation, represents all aspects that are part of the PROXIDRUGS consortium. Working together, we are excited to continue the collaboration and impact health worldwide.

Link to press release

bottom of page